Literature DB >> 32550135

Magnetic resonance cholangiopancreatography at 3T in a single breath-hold: comparative effectiveness between three-dimensional (3D) gradient- and spin-echo and two-dimensional (2D) thick-slab fast spin-echo acquisitions.

Cheng-Ping Chien1,2, Feng-Mao Chiu3, Yen-Chun Shen2, Yi-Hsun Chen2, Hsiao-Wen Chung1.   

Abstract

BACKGROUND: To compare the depiction conspicuity of three-dimensional (3D) magnetic resonance cholangiopancreatography (MRCP) based on gradient- and spin-echo (GRASE) and two-dimensional (2D) thick-slab MRCP using fast spin-echo (FSE) in different segments of hepatic and pancreatic ducts at 3T.
METHODS: Both 3D GRASE and 2D thick-slab FSE MRCP, with parameters adjusted under the constraints of specific absorption rate and scan time within single breath-hold, were performed for 95 subjects (M/F =49:46; age range, 25-75) at 3T. Conspicuity of eight ductal segments was graded by two experienced raters using a 4-point score. Situations where one technique is superior or inferior to the other were recorded.
RESULTS: 3D GRASE MRCP outperformed 2D thick-slab FSE MRCP in the common bile duct and common hepatic ducts (both with P<0.001), but compared inferiorly in the right hepatic ducts (P<0.001), right posterior hepatic ducts (P<0.005) and pancreatic duct distal (P<0.05). Performing both 3D and 2D MRCP would reduce the number of non-diagnostic readings in the left hepatic duct to 10 remaining (5.3%), compared with 31 (16.3%) or 21 (11.1%) out of 190 readings if using 3D GRASE or 2D thick-slab FSE alone, respectively.
CONCLUSIONS: Although 3D GRASE MRCP is preferential to visualize the common bile duct and common hepatic duct within one single breath-hold, the complementary role of 2D thick-slab FSE MRCP in smaller hepatic and pancreatic ducts makes it a useful adjunct if performed additionally. 2020 Quantitative Imaging in Medicine and Surgery. All rights reserved.

Entities:  

Keywords:  Two-dimensional thick-slab acquisition (2D thick-slab acquisition); breath-hold; gradient- and spin-echo (GRASE); magnetic resonance cholangiopancreatography (MRCP); three-dimensional imaging (3D imaging)

Year:  2020        PMID: 32550135      PMCID: PMC7276370          DOI: 10.21037/qims.2020.04.14

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN: 2223-4306


  28 in total

Review 1.  Pitfalls in MR cholangiopancreatographic interpretation.

Authors:  H Irie; H Honda; T Kuroiwa; K Yoshimitsu; H Aibe; K Shinozaki; K Masuda
Journal:  Radiographics       Date:  2001 Jan-Feb       Impact factor: 5.333

2.  Possible biliary disease: diagnostic performance of high-spatial-resolution isotropic 3D T2-weighted MRCP.

Authors:  Kiran R Nandalur; Hero K Hussain; William J Weadock; Erik J Wamsteker; Timothy D Johnson; Asra S Khan; Anthony R D'Amico; Matthew K Ford; Sirisha R Nandalur; Thomas L Chenevert
Journal:  Radiology       Date:  2008-10-21       Impact factor: 11.105

3.  Modified breath-hold compressed-sensing 3D MR cholangiopancreatography with a small field-of-view and high resolution acquisition: Clinical feasibility in biliary and pancreatic disorders.

Authors:  Liang Zhu; Huadan Xue; Zhaoyong Sun; Tianyi Qian; Elisabeth Weiland; Bernd Kuehn; Patrick Asbach; Bernd Hamm; Zhengyu Jin
Journal:  J Magn Reson Imaging       Date:  2018-04-14       Impact factor: 4.813

Review 4.  Can MRCP replace ERCP?

Authors:  Y Takehara
Journal:  J Magn Reson Imaging       Date:  1998 May-Jun       Impact factor: 4.813

5.  Magnetic resonance cholangiopancreatography with GRASE sequence at 3.0T: does it improve image quality and acquisition time as compared with 3D TSE?

Authors:  Morikatsu Yoshida; Takeshi Nakaura; Taihei Inoue; Shota Tanoue; Sentaro Takada; Daisuke Utsunomiya; Shota Tsumagari; Kazunori Harada; Yasuyuki Yamashita
Journal:  Eur Radiol       Date:  2018-01-15       Impact factor: 5.315

6.  In vitro and clinical studies of image acquisition in breath-hold MR cholangiopancreatography: single-shot projection technique versus multislice technique.

Authors:  Y Yamashita; Y Abe; Y Tang; J Urata; S Sumi; M Takahashi
Journal:  AJR Am J Roentgenol       Date:  1997-06       Impact factor: 3.959

7.  Magnetic resonance cholangiopancreatography at 3 Tesla: Image quality comparison between 3D compressed sensing and 2D single-shot acquisitions.

Authors:  Fabian K Lohöfer; Georgios A Kaissis; Michael Rasper; Christoph Katemann; Andreas Hock; Johannes M Peeters; Christoph Schlag; Ernst J Rummeny; Dimitrios Karampinos; Rickmer F Braren
Journal:  Eur J Radiol       Date:  2019-04-15       Impact factor: 3.528

8.  Pineapple juice as a negative oral contrast agent in magnetic resonance cholangiopancreatography: a preliminary evaluation.

Authors:  R D Riordan; M Khonsari; J Jeffries; G F Maskell; P G Cook
Journal:  Br J Radiol       Date:  2004-12       Impact factor: 3.039

9.  GRASE Revisited: breath-hold three-dimensional (3D) magnetic resonance cholangiopancreatography using a Gradient and Spin Echo (GRASE) technique at 3T.

Authors:  Ju Gang Nam; Jeong Min Lee; Hyo-Jin Kang; Sang Min Lee; Eunju Kim; Johannes M Peeters; Jeong Hee Yoon
Journal:  Eur Radiol       Date:  2018-02-01       Impact factor: 5.315

10.  Breath-held MR cholangiopancreatography (MRCP) using a 3D Dixon fat-water separated balanced steady state free precession sequence.

Authors:  James F Glockner; Manojkumar Saranathan; Ersin Bayram; Christine U Lee
Journal:  Magn Reson Imaging       Date:  2013-07-20       Impact factor: 2.546

View more
  2 in total

1.  Three-dimensional static-fluid MR urography with gradient- and spin-echo (GRASE) at 3.0T: comparison of image quality and diagnostic performance with respiratory-triggered fast spin-echo (FSE).

Authors:  Wei Wang; Junzhe Yang; Jing Liu; Wei Li; Kai Zhao; Ke Xue; Yongming Dai; Jianxing Qiu
Journal:  Abdom Radiol (NY)       Date:  2022-03-02

2.  Oral effervescent agent improving magnetic resonance cholangiopancreatography.

Authors:  Heon-Ju Kwon; Kyoung Won Kim; Kyung A Kang; Mi Sung Kim; So Yeon Kim; Taeyong Park; Jeongjin Lee
Journal:  Quant Imaging Med Surg       Date:  2022-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.